Adult height and cancer mortality in Asia: The Asia Pacific Cohort Studies Collaboration

Annals of Oncology

Volumn 21, Issue 3, 2009, Pages 646-654

  Batty, G D ^a,b   Barzi, F ^b   Woodward, M ^b,c   Jamrozik, K ^d   Woo, J ^e   Kim, H C ^f   Ueshima, H ^g   Huxley, R R ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f Yonsei University College of Medicine   (South Korea)

^g SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Asia; Body height; Cancer; Malignancy; Stature

Indexed keywords

ADULT; ARTICLE; ASIA; ASIAN; AUSTRALIA AND NEW ZEALAND; BLADDER CANCER; BODY HEIGHT; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE CANCER; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVARY CANCER; PANCREAS CANCER; POPULATION BASED CASE CONTROL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SEX DIFFERENCE; STOMACH CANCER;

ADULT; AGED; ASIA; AUSTRALASIA; BODY HEIGHT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77949591186     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp363     Document Type: Article

References (36)

1. Kuh D, Ben Shlomo Y. A Lifecourse Approach to Chronic Disease Epidemiology. Oxford: Oxford Medical Publications 2004.
2. Gunnell D. Can adult anthropometry be used as a 'biomarker' for prenatal and childhood exposures? Int J Epidemiol 2002; 31: 390-394.
3. Langenberg C, Shipley MJ, Batty GD, Marmot MG. Adult socioeconomic position and the association between height and coronary heart disease mortality: findings from 33 years of follow-up in the Whitehall Study. Am J Public Health 2005; 95: 628-632.
4. Kannam JP, Levy D, Larson M, Wilson PW. Short stature and risk for mortality and cardiovascular disease events. The Framingham Heart Study. Circulation 1994; 90: 2241-2247.
5. Lawlor DA, Taylor M, Davey SG et al. Associations of components of adult height with coronary heart disease in postmenopausal women: the British women's heart and health study. Heart 2004; 90: 745-749.
6. Morris JN, Kagan A, Pattison DC, Gardner MJ. Incidence and prediction of ischaemic heart-disease in London busmen. Lancet 1966; 2: 553-559.
7. Wannamethee SG, Shaper AG, Whincup PH, Walker M. Adult height, stroke and coronary heart disease. Am J Epidemiol 1998; 148: 1069-1076.
8. Yarnell JW, Limb ES, Layzell JM, Baker IA. Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies. Eur Heart J 1992; 13: 1602-1605.
9. Gunnell D, Okasha M, Davey Smith G et al. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 2001; 23: 313-342.
10. Batty GD, Shipley M, Gunnell D et al. Height, wealth, and health: an overview with new data from three longitudinal studies. Econ Hum Biol 2009; 7: 137-152.
11. Albanes D, Winick M. Are cell number and cell proliferation risk factors for cancer? J Natl Cancer Inst 1988; 80: 772-774.
12. Holly JM, Gunnell DJ, Davey SG. Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J Endocrinol 1999; 162: 321-330.
13. Batty GD, Shipley MJ, Langenberg C et al. Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study. Ann Oncol 2006; 17: 157-166.
14. Batty GD. Confounding effect of socioeconomic position in the study of height in relation to prostate cancer risk [letter]. Br J Cancer 2004; 90: 1875.
15. Weiss NS. Can the "specificity" of an association be rehabilitated as a basis for supporting a causal hypothesis? Epidemiology 2002; 13: 6-8.
16. Song YM, Davey Smith G, Sung J. Adult height and cause-specific mortality: a large prospective study of South Korean men. Am J Epidemiol 2003; 158: 479-485.
17. Song YM, Sung J. Adult height and the risk of mortality in South Korean women. Am J Epidemiol 2008; 168: 497-505.
18. Davey Smith G, Hart C, Upton M. Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality. J Epidemiol Community Health 2000; 54: 97-103.
19. Lee CM, Barzi F, Woodward M et al. Adult height and the risks of cardiovascular disease and major causes of death in the Asia-Pacific region: 21 000 deaths in 510 000 men and women. Int J Epidemiol 2009; 38: 1060-1071.
20. Woodward M, Barzi F, Martiniuk A et al. Cohort profile: the Asia Pacific Cohort Studies Collaboration. Int J Epidemiol 2006; 35: 1412-1416.
21. Anon. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death (Ninth Revision). Geneva, Switzerland: WHO 1977.
22. Anon. Classification of Diseases. 10th Revision. Copenhagen, Denmark: Danish National Board of Health 1993.
23. Woodward M. Epidemiology: Study Design and Data Analysis. Boca Raton, FL: Chapman & Hall/CRC 2005.
24. Huxley R, Jamrozik K, Lam TH et al. Impact of smoking and smoking cessation on lung cancer mortality in the Asia-Pacific region. Am J Epidemiol 2007; 165: 1280-1286.
25. Huxley R. The impact of modifiable risk factors on mortality from prostate cancer in populations of the Asia-Pacific region. Asian Pac J Cancer Prev 2007; 8: 199-205.
26. Ansary-Moghaddam A, Huxley R, Barzi F et al. The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol Biomarkers Prev 2006; 15: 2435-2440.
27. Hart RW, Turturro A. Dietary restrictions and cancer. Environ Health Perspect 1997; 105 (Suppl 4): 989-992.
28. Shimokawa I, Higami Y. Effect of Dietary Restriction on Pathological Processes. Modulation of Aging Processes by Dietary Restriction. London: CRC Press 1994; 247-266.
29. Ruggeri BA, Klurfeld DM, Kritchevsky D, Furlanetto RW. Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res 1989; 49: 4130-4134.
30. Juul A, Bang P, Hertel NT et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994; 78: 744-752.
31. Renehan AG, Zwahlen M, Minder C et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363: 1346-1353.
32. Hebert PR, Ajani U, Cook NR et al. Adult height and incidence of cancer in male physicians (United States). Cancer Causes Control 1997; 8: 591-597.
33. Heikkila K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 2007; 61: 824-833.
34. Gunnell D, May M, Ben Shlomo Y et al. Height, leg length, and cancer: the Caerphilly Study. Nutr Cancer 2003; 47: 34-39.
35. Gunnell DJ, Davey Smith G, Holly JM, Frankel S. Leg length and risk of cancer in the Boyd Orr cohort. BMJ 1998; 317: 1350-1351.
36. Gunnell DJ, Davey Smith G, Frankel S et al. Childhood leg length and adult mortality: follow up of the Carnegie (Boyd Orr) Survey of Diet and Health in Pre-war Britain. J Epidemiol Community Health 1998; 52: 142-152.